Evotec (OTCMKTS:EVTCY) Shares Pass Below 200 Day Moving Average – Time to Sell?

Evotec SE (OTCMKTS:EVTCY) shares passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $4.25 and traded as low as $4.00. Evotec shares last traded at $4.04, with a volume of 48,150 shares.

Evotec Stock Up 1.7 %

The firm has a 50 day moving average of $4.62 and a two-hundred day moving average of $4.24. The stock has a market capitalization of $1.36 billion, a PE ratio of 10.02 and a beta of 0.98. The company has a current ratio of 2.57, a quick ratio of 2.50 and a debt-to-equity ratio of 0.53.

Evotec Company Profile

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.